Treatment of serious calcium channel blocker overdose with levosimendan, a calcium sensitizer

Anesthesia and Analgesia

Volumn 108, Issue 3, 2009, Pages 790-792

  Varpula, Tero ^a   Rapola, Janne ^b   Sallisalmi, Marko ^b   Kurola, Jouni ^c  

^a JORVI HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ATROPINE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM SENSITIZER; GLUCAGON; LEVOSIMENDAN; NORADRENALIN; OXYGEN; VERAPAMIL; AMLODIPINE; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN; VASOCONSTRICTOR AGENT;

ADULT; ARTERIAL PRESSURE; ARTERY CATHETER; ARTICLE; BLOOD GAS ANALYSIS; CARDIOVASCULAR SYSTEM; CAROTID ARTERY PULSE; CASE REPORT; DRUG DOSE INCREASE; DRUG OVERDOSE; ENDOTRACHEAL INTUBATION; FEMALE; HEART PACING; HEART RATE; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; MALE; OXYGEN SATURATION; PRIORITY JOURNAL; RESUSCITATION; SHOCK; SINUS RHYTHM; BLOOD; CHEMICALLY INDUCED DISORDER; COMA; ECHOCARDIOGRAPHY; INTOXICATION; LACTIC ACIDOSIS; MIDDLE AGED;

ACIDOSIS, LACTIC; AMLODIPINE; CALCIUM CHANNEL BLOCKERS; CARDIOTONIC AGENTS; COMA; ECHOCARDIOGRAPHY; EPINEPHRINE; FEMALE; HEMODYNAMICS; HUMANS; HYDRAZONES; MALE; MIDDLE AGED; OVERDOSE; PYRIDAZINES; SHOCK; VASOCONSTRICTOR AGENTS; VERAPAMIL;

EID: 61949220687     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181931737     Document Type: Article

References (18)

1. Hofer CA, Smith KJ, Tenholder MF. Verapamil intoxication: a literature review of overdoses and discussion of therapeutic options. Am J Med 1993;95:431-8
2. Olson KR, Erdman AR, Woolf AD, Scharman EJ, Christianson G, Caravati EM, Wax PM, Booze LL, Manoguerra AS, Keyes DC, Chyka PA, Troutman WG, American Association of Poison Control C. Calcium channel blocker ingestion: an evidencebased consensus guideline for out-of-hospital management. Clin Toxicol 2005;43:797-822
3. Kenny J. Treating overdose with calcium channel blockers. BMJ 1994;308:992-3
4. Shepherd G. Treatment of poisoning caused by beta-adrenergic and calcium-channel blockers. Am J Health Syst Pharm 2006;63:1828-35
5. Rygnestad T, Moen S, Wahba A, Lien S, Ingul CB, Schrader H, Knapstad SE. Severe poisoning with sotalol and verapamil. Recovery after 4 h of normothermic CPR followed by extra corporeal heart lung assist. Acta Anaesthesiol Scand 2005; 49:1378-80
6. Innes CA, Wagstaff AJ. Levosimendan: a review of its use in the management of acute decompensated heart failure. Drugs 2003;63:2651-71
7. Hasenfuss G, Pieske B, Castell M, Kretschmann B, Maier LS, Just H. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation 1998;98:2141-7
8. Haikala H, Nissinen E, Wall P, Levijoki J, Linden IB. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 1995;27:1859-66
9. Haikala H, Etemadzadeh E, Levijoki J, Linden IB. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 1995; 25:794-801
10. Pollesello P, Mebazaa A. ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction. Curr Opin Crit Care 2004;10:436-41
11. Stehr SN, Christ T, Rasche B, Rasche S, Wettwer E, Deussen A, Ravens U, Koch T, Hubler M. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations. Anesth Analg 2007;105:641-7
12. Huang L, Weil MH, Sun S, Cammarata G, Cao L, Tang W. Levosimendan improves postresuscitation outcomes in a rat model of CPR. J Lab Clin Med 2005;146:256-61
13. Huang L, Weil MH, Tang W, Sun S, Wang J. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction. Crit Care Med 2005;33:487-91
14. Graudins A, Najafi J, Rur-SC MP. Treatment of experimental verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity. Clin Toxicol 2007:1-7
15. Moiseyev VS, Päder P, Andrejevs N ym. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 2002;23:1422-8
16. Bailey B. Glucagon in beta-blocker and calcium channel blocker overdoses: a systematic review. J Toxicol Clin Toxicol. 2003;41:595-602
17. Lheureux PE, Zahir S, Gris M, Derrey AS, Penaloza A. Benchto- bedside review: hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers. Crit Care 2006;10:212
18. Kanagarajan K, Marraffa JM, Bouchard NC, Krishnan P, Hoffman RS, Stork CM. The use of vasopressin in the setting of recalcitrant hypotension due to calcium channel blocker overdose. Clin Toxicol 2007;45:56-9